JP Morgan Chase’s Vivani Medical VANI Stock Holding History

JP Morgan Chase’s Portfolio VANI Stock Details VANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.1K	Sell	3,389 -102	-3%	-$123	﹤0.01%	7100
2026 Q1	$3.27K	Buy	+3,491	New	+$4.37K	﹤0.01%	6941
2025 Q2	–	Sell	-66	Closed	-$69	–	7673
2025 Q1	$69	Sell	66 -5	-7%	-$6	﹤0.01%	6924
2024 Q4	$82	Buy	+71	New	+$90	﹤0.01%	7044
2024 Q1	–	Sell	-103	Closed	-$105	–	7915
2023 Q4	$105	Buy	103 +53	+106%	+$53	﹤0.01%	7118
2023 Q3	$51	Buy	50 +31	+163%	+$34	﹤0.01%	6999
2023 Q2	$23	Hold	19	–	–	﹤0.01%	6784
2023 Q1	$0	Hold	19	–	–	﹤0.01%	7247
2022 Q4	$0	Hold	19	–	–	﹤0.01%	7025
2022 Q3	$0	Buy	+19	New	+$90	﹤0.01%	6879
2021 Q3	–	Sell	-21	Closed	–	–	6828
2021 Q2	$0	Buy	+21	New	+$406	﹤0.01%	6629
2018 Q3	–	Sell	-4,242	Closed	-$169K	–	5841
2018 Q2	$169K	Buy	+4,242	New	+$185K	﹤0.01%	4632
2018 Q1	–	Sell	-7,032	Closed	-$322K	–	5649
2017 Q4	$322K	Buy	+7,032	New	+$234K	﹤0.01%	4260
2016 Q3	–	Sell	-35	Closed	-$3K	–	4826
2016 Q2	$3K	Buy	+35	New	+$3.64K	﹤0.01%	4557
2016 Q1	–	Sell	-289	Closed	-$41K	–	4962
2015 Q4	$41K	Buy	+289	New	+$42.3K	﹤0.01%	3953

Other funds holding VANI

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TWM

Tanager Wealth Management Goring On Thames, United Kingdom $1.15B AUM 19.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MMG

Monetary Management Group St Louis, Missouri $487M AUM 49.37% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase's VANI Position: Q2 2026 in Review

JP Morgan Chase reduced its Vivani Medical (VANI) stake by 2.9% in Q2 2026, selling an estimated $123 and leaving 3,389 shares worth $4.1K. The position accounts for ﹤0.01% of the portfolio, ranked #7100.

JP Morgan Chase first reported a position in VANI in Q4 2015 and has held it in 15 quarters since. The position peaked at $322K in Q4 2017. 38 funds tracked by Wall St. Rank hold VANI as of Q2 2026.

JP Morgan Chase held 3,389 shares of Vivani Medical worth $4.1K as of Q2 2026.
JP Morgan Chase sold 102 Vivani Medical shares in Q2 2026, an estimated $123.
Vivani Medical made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7100 holding.
JP Morgan Chase first reported a position in Vivani Medical in Q4 2015 and has held it in 15 quarters since.
JP Morgan Chase's Vivani Medical position peaked at $322K in Q4 2017.
38 funds tracked by Wall St. Rank held Vivani Medical as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.